Shamburg News · 8-K filed Nov 17, 2026, 5:20 PM EST
DataMEDS AI Establishes At-the-Market Stock Sales Agreement With Dawson James Securities
MEDS · DataMeds AI, Inc.
- Financing
- Other event
- Materiality: medium
DataMEDS AI, Inc. entered into an ATM sales agreement on November 16, 2026 with Dawson James Securities, Inc., allowing it to offer and sell common stock from time to time through the sales agent up to a maximum amount set forth in the agreement. The shares are offered under a Form S-3 shelf registration statement declared effective May 7, 2026 and a prospectus supplement dated November 17, 2026. Counsel's legality opinion is filed as Exhibit 5.1.
Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001493152-26-052897.
Written from the filing by Shamburg Markets. Figures are as reported by the company.